Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy

The complement system plays a key role in myasthenia gravis (MG). Anti-complement drugs are emerging as effective therapies to treat anti-acetylcholine receptor (AChR) antibody-positive MG patients, though their usage is still limited by the high costs. Here, we searched for plasma complement protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacomino, Nicola, Vanoli, Fiammetta, Frangiamore, Rita, Ballardini, Marta, Scandiffio, Letizia, Bortone, Federica, Andreetta, Francesca, Baggi, Fulvio, Bernasconi, Pia, Antozzi, Carlo, Cavalcante, Paola, Mantegazza, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220000/
https://www.ncbi.nlm.nih.gov/pubmed/35740382
http://dx.doi.org/10.3390/biomedicines10061360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220000/
https://www.ncbi.nlm.nih.gov/pubmed/35740382
http://dx.doi.org/10.3390/biomedicines10061360

Ejemplares similares